Clinical services for AIDS patients at the University of California, San Francisco (UCSF) expanded rapidly from the onset of the epidemic and became particularly focused at the San Francisco General Hospital (SFGH) Campus under the directorship of Paul A. Volberding, M.D. The J. David Gladstone Foundation decided to extend their organization's research activities beyond atherosclerosis to basic AIDS research. Since the Gladstone Foundation Laboratories were already located at SFGH and SFGH was also the site of one of the earliest AIDS medical care facilities, and now an internationally recognized treatment center for HIV-infected persons and AIDS patients, extending the organization to basic science in AIDS was a natural choice. In a joint effort between the Trustees of the Gladstone Foundation, the City and County of San Francisco, and UCSF, resources were combined to complete, furnish and equip a 27,000 square foot facility dedicated to basic research on AIDS. This facility is the Gladstone Institute of Virology and Immunology and is directed by an internationally recognized immunologist and virologist, Warner C. Greene, M.D., Ph.D. The CFAR theme of transnational research will be set by the shared responsibilities of Co-Directors, Drs. Volberding and Greene and by inclusion of the following core facilities: A) Clinical, with Biostatistical, Behavioral and Tissue Bank sub-cores, B) Clinical Virology, C) Flow Cytometry D) Molecular Biology, and E) Immunocytopathology. Usage of these core facilities will be targeted at multidisciplinary collaborations. Developmental activities of the UCSF CFAR will include New Investigator Awards, Pilot Project Grants and short term support for Evolving Research Opportunities. The UCSF CFAR will also continue to support focused scientific workshop which will be designed to bring UCSF investigators together with key outside scientists to facilitate an effective, collaborative approach among UCSF investigators in key areas. The current application continues the involvement of many of the established UCSF investigator from the original CFAR but also serves to build on the new research base within the Gladstone Institute of Virology and Immunology. The proposed CFAR represents an important evolution in the history of the San Francisco CFAR and specifically seeks to bridge the gap between the clinical and basic science disciplines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH059037-14
Application #
6363722
Study Section
Special Emphasis Panel (ZAI1-SCO-A (J1))
Program Officer
Rausch, Dianne M
Project Start
1988-09-30
Project End
2003-02-28
Budget Start
2001-05-10
Budget End
2003-02-28
Support Year
14
Fiscal Year
2001
Total Cost
$1,466,696
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Josefsson, Lina; von Stockenstrom, Susanne; Faria, Nuno R et al. (2013) The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci U S A 110:E4987-96
Josefsson, Lina; Eriksson, Susanne; Sinclair, Elizabeth et al. (2012) Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. J Infect Dis 206:28-34
Papasavvas, Emmanouil; Hsue, Priscilla; Reynolds, Griffin et al. (2012) Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects. Antivir Ther 17:557-63
Hunt, Peter W; Landay, Alan L; Sinclair, Elizabeth et al. (2011) A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One 6:e15924
Hunt, Peter W; Hatano, Hiroyu; Sinclair, Elizabeth et al. (2011) HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers. Clin Infect Dis 52:681-7
Hunt, Peter W; Cao, Huyen L; Muzoora, Conrad et al. (2011) Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 25:2123-31
Kitchen, Christina M R; Yeghiazarian, Lilit; Hoh, Rebecca et al. (2011) Immune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection. PLoS One 6:e21190
Favre, David; Stoddart, Cheryl A; Emu, Brinda et al. (2011) HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells. Blood 117:2189-99
Hunt, Peter W; Martin, Jeffrey N; Sinclair, Elizabeth et al. (2011) Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis 203:1474-83
Favre, David; Mold, Jeff; Hunt, Peter W et al. (2010) Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2:32ra36

Showing the most recent 10 out of 157 publications